| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0005 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |